Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Exposure to new environments and diseases can put travellers at an increased risk of serious illness. Travel vaccines against diseases such as hepatitis A and B, rabies, typhoid and cholera
The global Travel Vaccines market was valued at US$ 5469.1 million in 2023 and is anticipated to reach US$ 9386.9 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.
However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Travel Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travel Vaccines.
Report Scope
The Travel Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Travel Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Travel Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
Consumption by Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Travel Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Travel Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Travel Vaccines Market Overview
1.1 Product Overview and Scope of Travel Vaccines
1.2 Travel Vaccines Segment by Type
1.2.1 Global Travel Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Cholera
1.2.3 Rabies Vaccine
1.2.4 Hepatitis
1.2.5 Typhoid
1.3 Travel Vaccines Segment by Application
1.3.1 Global Travel Vaccines Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Travel Vaccines Market Size Estimates and Forecasts
1.4.1 Global Travel Vaccines Revenue 2019-2030
1.4.2 Global Travel Vaccines Sales 2019-2030
1.4.3 Global Travel Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Travel Vaccines Market Competition by Manufacturers
2.1 Global Travel Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Travel Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Travel Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Travel Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Travel Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Travel Vaccines, Product Type & Application
2.7 Travel Vaccines Market Competitive Situation and Trends
2.7.1 Travel Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Travel Vaccines Players Market Share by Revenue
2.7.3 Global Travel Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Travel Vaccines Retrospective Market Scenario by Region
3.1 Global Travel Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Travel Vaccines Global Travel Vaccines Sales by Region: 2019-2030
3.2.1 Global Travel Vaccines Sales by Region: 2019-2024
3.2.2 Global Travel Vaccines Sales by Region: 2025-2030
3.3 Global Travel Vaccines Global Travel Vaccines Revenue by Region: 2019-2030
3.3.1 Global Travel Vaccines Revenue by Region: 2019-2024
3.3.2 Global Travel Vaccines Revenue by Region: 2025-2030
3.4 North America Travel Vaccines Market Facts & Figures by Country
3.4.1 North America Travel Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Travel Vaccines Sales by Country (2019-2030)
3.4.3 North America Travel Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Travel Vaccines Market Facts & Figures by Country
3.5.1 Europe Travel Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Travel Vaccines Sales by Country (2019-2030)
3.5.3 Europe Travel Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Travel Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Travel Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Travel Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Travel Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Travel Vaccines Market Facts & Figures by Country
3.7.1 Latin America Travel Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Travel Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Travel Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Travel Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Travel Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Travel Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Travel Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Travel Vaccines Sales by Type (2019-2030)
4.1.1 Global Travel Vaccines Sales by Type (2019-2024)
4.1.2 Global Travel Vaccines Sales by Type (2025-2030)
4.1.3 Global Travel Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Travel Vaccines Revenue by Type (2019-2030)
4.2.1 Global Travel Vaccines Revenue by Type (2019-2024)
4.2.2 Global Travel Vaccines Revenue by Type (2025-2030)
4.2.3 Global Travel Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Travel Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Travel Vaccines Sales by Application (2019-2030)
5.1.1 Global Travel Vaccines Sales by Application (2019-2024)
5.1.2 Global Travel Vaccines Sales by Application (2025-2030)
5.1.3 Global Travel Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Travel Vaccines Revenue by Application (2019-2030)
5.2.1 Global Travel Vaccines Revenue by Application (2019-2024)
5.2.2 Global Travel Vaccines Revenue by Application (2025-2030)
5.2.3 Global Travel Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Travel Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Travel Vaccines Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Travel Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Travel Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Travel Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Jintan
6.5.1 Jintan Corporation Information
6.5.2 Jintan Description and Business Overview
6.5.3 Jintan Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jintan Travel Vaccines Product Portfolio
6.5.5 Jintan Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CSL Travel Vaccines Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 MedImmune LLC
6.6.1 MedImmune LLC Corporation Information
6.6.2 MedImmune LLC Description and Business Overview
6.6.3 MedImmune LLC Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MedImmune LLC Travel Vaccines Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Corporation Information
6.8.2 J&J(Crucell) Description and Business Overview
6.8.3 J&J(Crucell) Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 J&J(Crucell) Travel Vaccines Product Portfolio
6.8.5 J&J(Crucell) Recent Developments/Updates
6.9 China National Biotec
6.9.1 China National Biotec Corporation Information
6.9.2 China National Biotec Description and Business Overview
6.9.3 China National Biotec Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China National Biotec Travel Vaccines Product Portfolio
6.9.5 China National Biotec Recent Developments/Updates
6.10 Tiantan
6.10.1 Tiantan Corporation Information
6.10.2 Tiantan Description and Business Overview
6.10.3 Tiantan Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tiantan Travel Vaccines Product Portfolio
6.10.5 Tiantan Recent Developments/Updates
6.11 Hualan
6.11.1 Hualan Corporation Information
6.11.2 Hualan Travel Vaccines Description and Business Overview
6.11.3 Hualan Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Travel Vaccines Product Portfolio
6.11.5 Hualan Recent Developments/Updates
6.12 Kangtai
6.12.1 Kangtai Corporation Information
6.12.2 Kangtai Travel Vaccines Description and Business Overview
6.12.3 Kangtai Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kangtai Travel Vaccines Product Portfolio
6.12.5 Kangtai Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Corporation Information
6.13.2 Hissen Travel Vaccines Description and Business Overview
6.13.3 Hissen Travel Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hissen Travel Vaccines Product Portfolio
6.13.5 Hissen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Travel Vaccines Industry Chain Analysis
7.2 Travel Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Travel Vaccines Production Mode & Process
7.4 Travel Vaccines Sales and Marketing
7.4.1 Travel Vaccines Sales Channels
7.4.2 Travel Vaccines Distributors
7.5 Travel Vaccines Customers
8 Travel Vaccines Market Dynamics
8.1 Travel Vaccines Industry Trends
8.2 Travel Vaccines Market Drivers
8.3 Travel Vaccines Market Challenges
8.4 Travel Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research